|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.62 USD | +3.51% |
|
+0.95% | +72.68% |
| 10-12 | ImmuCell Q3 Preliminary Sales Rise | MT |
| 10-12 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | +3.51% | +0.95% | +72.68% | +72.40% | +19.33% | 96.45M |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
